Lupin Ltd is the pharmaceutical company that has to foray into diagnostics to leverage its ‘doctor connect to tap a sector that has low entry barriers, gives high returns on capital employed, and is witnessing double-digit growth. A formal launch is expected next month, media reported.
- BSE-NSE Holiday List 2025: Stock Market Holiday List 2025
- Welspun Corp Shares Trade 1% High on Securing Order Worth Rs 130 Crore
- Ola Electric Shares Soar 6% on Opening 3,200 Stores
- Panacea Biotec Shares Hit 5% Upper Circuit on Securing Rs 127 Crore Order
- Bharat Petroleum Shares Gain 2% on Securing 150 MW Power Project
Lupin Diagnostics will be a part of Lupin Healthcare, a 100 per cent subsidiary of Lupin. It is in the process of recruiting the team, finalising franchise partners, and setting up a 45,000 square feet laboratory in Navi Mumbai.
Stock Covered in the news